Company Profile
Aura Biosciences Stock Price, News & Analysis
- Ticker:
- AURA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Aura Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
7.02 USD (+1.01%)
Close
Last updated: June 23, 2026 at 00:00
725.77M USD
Market cap
Why the stock is moving
AURA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Aura Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Aura Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Aura Biosciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Aura Biosciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Aura Biosciences (AURA)?
Aura Biosciences (AURA) most recently closed at 7.02 USD, a +1.01% move versus the previous session.
What is the market cap of Aura Biosciences (AURA)?
Aura Biosciences currently has a market capitalization of 725.77M USD on BioPharmSignal.
What does Aura Biosciences do?
Aura Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is AURA stock listed?
Aura Biosciences (AURA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Aura Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Aura?
Aura Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Aura Biosciences targeting with Aura?
Aura Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biosciences?
Aura Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.